143 Afleveringen

  1. Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review

    Gepubliceerd: 2-2-2023
  2. Basics of prostate cancer pathology

    Gepubliceerd: 26-1-2023
  3. Oligometastaic breast cancer

    Gepubliceerd: 19-1-2023
  4. Artificial intelligence for prediction of treatment outcomes in breast cancer: Systematic review of design, reporting standards, and bias

    Gepubliceerd: 12-1-2023
  5. Summary/Review - Reporting Guidelines - CHEERS

    Gepubliceerd: 6-12-2022
  6. Role of immunotherapy in head and neck cancer

    Gepubliceerd: 1-12-2022
  7. AYAs with cancer: the right to be forgotten

    Gepubliceerd: 24-11-2022
  8. Summary/Review - Reporting Guidelines - SQUIRE

    Gepubliceerd: 17-11-2022
  9. Male breast cancer

    Gepubliceerd: 10-11-2022
  10. Summary/Review - Reporting Guidelines - SRQR

    Gepubliceerd: 3-11-2022
  11. Summary/Review - Reporting Guidelines - AGREE

    Gepubliceerd: 27-10-2022
  12. Breast Cancer: Frequently Asked Questions and Answers

    Gepubliceerd: 20-10-2022
  13. The role of Medical Physicist in Oncology

    Gepubliceerd: 13-10-2022
  14. How to approach to breast cancer patient who had not received neoadjuvant chemo and staged T2NO postoperatively?

    Gepubliceerd: 6-10-2022
  15. Parp inhibitors in ovarian cancer

    Gepubliceerd: 29-9-2022
  16. Primary endocrine resistant in recurrent locoregional only Breast cancer (role of endocrine therapy)

    Gepubliceerd: 22-9-2022
  17. Should Prostate Cancer Patients With History of Cardiovascular Events Be Preferentially Treated With Luteinizing Hormone-Releasing Hormone Antagonists?

    Gepubliceerd: 15-9-2022
  18. The use of Lutetium PSMA as treatment in mCRPC – in what sequence and how to best select patients

    Gepubliceerd: 8-9-2022
  19. Use of Medical Cannabis in Oncology. Knowledges and attitudes among oncologist and patient.

    Gepubliceerd: 1-9-2022
  20. Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?

    Gepubliceerd: 27-7-2022

4 / 8

e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net

Visit the podcast's native language site